| Unadjusted HR (95% CI) | Unadjusted p-value | Adjusted HR (95% CI) | Adjusted p-value |
---|---|---|---|---|
Covariate | ||||
 Univariate | ||||
  Location of metastasis | 1.07 (0.46, 2.50) | 0.88 | 1.01 (0.47, 2.19) | 0.98 |
  Tumor size ≤2 cm | 0.40 (0.19, 0.88) | 0.02 | 0.44 (0.22, 0.88) | 0.02 |
  Histologya | 1.26 (0.30, 5.30) | 0.75 | 1.21 (0.31, 4.76) | 0.78 |
  Surgical resection | 1.44 (0.44, 4.75) | 0.54 | 1.42 (0.49, 4.12) | 0.52 |
  SF vs HF-SRS | 2.10 (1.03, 4.33) | 0.04 | 1.73 (0.90, 3.33) | 0.10 |
  Concurrent systemic therapy | 0.79 (0.35, 1.78) | 0.57 | 0.67 (0.31, 1.44) | 0.30 |
  Prior WBRT | 1.97 (0.96, 4.04) | 0.07 | 1.58 (0.82, 3.03) | 0.17 |
 Multivariate | ||||
  SF- vs HF-SRS | 1.99 (0.84, 4.76) | 0.12 | 1.65 (0.70, 3.87) | 0.25 |
  Tumor size ≤2 cm | 0.49 (0.20, 1.17) | 0.11 | 0.53 (0.23, 1.24) | 0.14 |
  Prior WBRT | 2.10 (0.92, 4.81) | 0.08 | 1.83 (0.77, 4.38) | 0.17 |